Enduring insulin immunoreactivity can be partially attributed to abundant insulin storage and high stability of insulin mRNA31, but assuming recombination occurred near the time of AAV injection, this seems inadequate to explain persistent near normal insulin storage (by comparing brightness of immunoreactivity to control cells) six weeks after recombination during a period of hyperglycemia. This evidence concerns the gene INS and Hyperglycemia.